| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.042 | 0.4 |